New Delhi [India], January 4 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is expected to meet on Tuesday afternoon to discuss Bharat Biotech's application for clinical trials of its intranasal Covid vaccine as a booster or a third dose.
Hyderabad (Telangana) [India], December 30 (ANI): Hyderabad based vaccine manufacturer Bharat Biotech on Thursday announced that Covaxin (BBV152) has been found to be "safe, well-tolerated, and immunogenic" in the age group of 2-18 years in phase II/III study, said a company's statement.
New Delhi [India], December 29 (ANI): With the Drug Controller General of India (DCGI) approving two new COVID-19 vaccines and one anti-viral drug for emergency use on Tuesday, Dr Arjun Dang, CEO, Dr Dangs Lab, welcomed the announcement and said they feel immensely proud "to have been a p
New Delhi [India], December 29 (ANI): The Drug Controller General of India (DCGI) has given approval to the Hyderbad-based pharmaceutical company Biological E to conduct phase 3 clinical trials of its COVID-19 vaccine Corbevax as a booster dose, said sources.
Mumbai (Maharashtra) [India], December 28 (ANI): Giving a sneak peek into the dark world of human medical trials, the makers of 'Human' unveiled the intriguing trailer of the upcoming medical thriller on Tuesday.
New Delhi [India], December 26 (ANI): Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.
London [UK], December 23 (ANI): The University of Oxford, in collaboration with AstraZeneca, has announced interim trial data from its Phase III trials that show its candidate coronavirus vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of
Pune (Maharashtra) [India], December 21 (ANI): The Indian Army is getting new indigenously designed and developed anti-personnel and anti-tank mines which would act as the first line of defence against any attempt by adversaries on the China and Pakistan border to step on the Indian soil.
New Delhi [India], December 20 (ANI): As India is witnessing a surge in cases of "highly transmissible" Omicron variant, Hyderabad-based Bharat Biotech has submitted the phase 3 clinical trial application to the Drugs Controller General of India (DCGI) to get approval for the booster dose
New Delhi [India], December 20 (ANI): Indian Navy's second indigenous stealth destroyer of the P15B class, Mormugao, which was planned to be commissioned in mid-2022, proceeded on her maiden sea sortie on Sunday, said the Ministry of Defence.
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Mumbai (Maharashtra) [India], December 11 (ANI): The 19th Asian Games equestrian (showjumping) trials for the selections will take place from December 12-16, 2021 at the Amateur Riders Club at Mahalakshmi Racecourse, Mumbai.